A PHP Error was encountered

Severity: 8192

Message: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated

Filename: helpers/my_audit_helper.php

Line Number: 8900

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 8900
Function: str_replace

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3362
Function: formatAIDetailSummary

File: /var/www/html/application/controllers/Search.php
Line: 168
Function: pubMedSearch_Global

File: /var/www/html/index.php
Line: 316
Function: require_once

Siteman Cancer Center[Affiliation] Publications | LitMetric

2,725 results match your criteria: "Siteman Cancer Center[Affiliation]"

Association of late eating with colorectal adenomas: a cross-sectional study.

Eur J Nutr

December 2024

Rush Center for Integrated Microbiome and Chronobiology Research, Rush Medical College, Rush University Medical Center, Chicago, IL, 60612, USA.

Purpose: Colorectal cancer (CRC) is linked to lifestyle exposures. However, changes in the CRC rates among younger populations remain poorly understood and suggest the existence of yet unidentified factor(s) that may contribute to colon carcinogenesis. Here, we investigated the potential role of time of eating in the risk of pre-cancerous colonic neoplasms (tubular adenoma: TA).

View Article and Find Full Text PDF

PFAS Levels, Early Life Factors, and Mammographic Breast Density in Premenopausal Women.

Environ Health Perspect

September 2024

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

Background: Mammographic breast density (MBD) is a strong risk factor and an intermediate phenotype for breast cancer, yet there are limited studies on how environmental pollutants are associated with MBD.

Objective: We investigated associations of perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), and perfluorohexane sulfonate (PFHxS) levels with measures of MBD and evaluated if early life factors modified any associations.

Methods: Metabolon performed metabolomics analysis using ultrahigh-performance liquid chromatography/tandem accurate mass spectrometry in fasting blood from 705 premenopausal women completing their annual screening mammogram in St.

View Article and Find Full Text PDF

The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast.

Cancer Epidemiol Biomarkers Prev

December 2024

Division of General Medicine & Geriatrics, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Background: It remains unclear whether residential segregation impacts on clinical treatment and outcomes for ductal carcinoma in situ (DCIS), a nonobligate precursor to invasive breast cancer (IBC).

Methods: This population-based retrospective cohort study included adult non-Hispanic White and Black women diagnosed with unilateral DCIS between January 1990 and December 2015, followed through December 2016, and identified from the Surveillance, Epidemiology, and End Results dataset. County-level racialized economic segregation was measured using the Index of Concentration at the Extremes.

View Article and Find Full Text PDF

A qualitative exploration of disseminating research findings among public health researchers in China.

BMC Public Health

September 2024

Prevention Research Center, Brown School, Washington University in St. Louis, One Brookings Drive, Campus, Box 1196, St. Louis, MO, 63130, USA.

Background: Research dissemination is essential to accelerate the translating of evidence into practice. Little is known about dissemination among Chinese public health researchers. This study aimed to explore the understanding and practices of disseminating research findings and to identify barriers and facilitators that influence dissemination activities to non-research audiences.

View Article and Find Full Text PDF

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.

N Engl J Med

September 2024

From Dana-Farber Cancer Institute (J.A.C., J.A.M.), Boston Medical Center (M.H.K.), and Boston University (M.H.K.) - all in Boston; the Alliance Statistics and Data Management Center, Mayo Clinic (S.G., T.Z., S.P., F.-S.O.), and Mayo Clinic Comprehensive Cancer Center (T.R.H.) - both in Rochester, MN; Wright Center of Innovation and the Imaging and Radiation Oncology Core, University of Cincinnati, Cincinnati (M.V.K.), and the Ohio State University Comprehensive Cancer Center, Columbus (B.K.) - both in Ohio; the University of California, San Francisco, San Francisco (S.B.), and Stanford Cancer Center, Stanford (S.S.) - both in California; Alliance Statistics and Data Management Center, Mayo Clinic, Scottsdale, AZ (A.C.D.); the University of Hawaii Cancer Center, Honolulu (J.A.); the Alliance Protocol Operations Office, University of Chicago, Chicago (A.S.); Mount Sinai Medical Center (E.M.W.) and Memorial Sloan Kettering Cancer Center (N.R., E.M.O.) - both in New York; Washington University School of Medicine and Siteman Cancer Center, St. Louis (N.A.T.); the University of New Mexico Comprehensive Cancer Center, Albuquerque (B.T.); Fox Chase Cancer Center, Philadelphia (N.V.); M.D. Anderson Cancer Center, Houston (A.D.); Moffitt Cancer Center, Tampa, FL (J.R.S.); and the National Cancer Institute, Bethesda, MD (E.C.K.).

Background: Treatment options for patients with advanced neuroendocrine tumors are limited. The efficacy of cabozantinib in the treatment of previously treated, progressive extrapancreatic or pancreatic neuroendocrine tumors is unclear.

Methods: We enrolled two independent cohorts of patients - those with extrapancreatic neuroendocrine tumors and those with pancreatic neuroendocrine tumors - who had received peptide receptor radionuclide therapy or targeted therapy or both.

View Article and Find Full Text PDF

Multi-omic data-driven studies, characterizing complex disease signaling system from multiple levels, are at the forefront of precision medicine and healthcare. The integration and interpretation of multi-omic data are essential for identifying molecular targets and deciphering core signaling pathways of complex diseases. However, it remains an open problem due the large number of biomarkers and complex interactions among them.

View Article and Find Full Text PDF

Using National Public Health Accreditation to Explore Quality Improvement and Performance Management in Small Local Health Departments.

J Public Health Manag Pract

September 2024

Author Affiliations: Department of Health Policy and Organization (Drs Fifolt and Erwin), School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Prevention Research Center (Dr Allen, Mr Crenshaw, and Dr Brownson), Department of Surgery, Alvin J. Siteman Cancer Center and Division of Public Health Sciences (Dr Brownson), Brown School, Washington University in St. Louis, St. Louis, Missouri; and Public Health Accreditation Board (Ms Lang and Ms Thomas), Alexandria, Virginia.

Context: This article focuses on 4 small local health departments (LHDs) that were in the process of seeking Public Health Accreditation Board (PHAB) reaccreditation or Pathways Recognition using PHAB Standards & Measures Version 2022.

Objective: The objective of this study was to explore the experiences of 4 small LHDs related to Quality Improvement (QI) and Performance Management (PM) in their pursuit of PHAB reaccreditation or Pathways Recognition.

Design: A team of researchers conducted 22 qualitative interviews with health department leaders and staff.

View Article and Find Full Text PDF
Article Synopsis
  • * A multidisciplinary team of experts from various medical fields contributes to these guidelines, ensuring comprehensive care for patients with cancer-associated VTE.
  • * The guidelines provide specific evaluation processes and recommended treatment options tailored to the different types of cancer-associated VTE.
View Article and Find Full Text PDF
Article Synopsis
  • * These guidelines are designed to support physicians in making informed decisions about CRC screening for patients who do not have specific genetic syndromes.
  • * Recent updates include insights on both primary and secondary CRC prevention, particularly addressing when to start screening for average-risk individuals and those with a relevant personal history of cancer.
View Article and Find Full Text PDF

Prophylactic antibiotics for excision of premalignant vulvar lesions: A pilot randomized controlled trial.

Gynecol Oncol Rep

October 2024

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, and Alvin J. Siteman Cancer Center, St. Louis, MO, United States.

No prospective data have been described to inform guidelines on antibiotic prophylaxis for partial vulvectomies. Thus, we conducted a single-center, pilot, double-blind randomized controlled trial to assess the effectiveness of prophylactic antibiotics to prevent wound complications after partial vulvectomies. Patients were randomly assigned 1:1 to preoperative antibiotics or no preoperative antibiotics.

View Article and Find Full Text PDF

Tissue determinants of the human T cell receptor repertoire.

bioRxiv

August 2024

Department of Physiology & Biophysics, Institute for Immunology, Center for Virus Research, Vaccine Research & Development Center, and Cancer Research Institute, University of California Irvine, Irvine, CA, USA.

98% of T cells reside in tissues, yet nearly all human T cell analyses are performed from peripheral blood. We single-cell sequenced 5.7 million T cells from ten donors' autologous blood and tonsils and sought to answer key questions about T cell receptor biology previously unanswerable by smaller-scale experiments.

View Article and Find Full Text PDF

Inhibiting epigenetic modulators can transcriptionally reactivate transposable elements (TEs). These TE transcripts often generate unique peptides that can serve as immunogenic antigens for immunotherapy. Here, we ask whether TEs activated by epigenetic therapy could appreciably increase the antigen repertoire in glioblastoma, an aggressive brain cancer with low mutation and neoantigen burden.

View Article and Find Full Text PDF

Multiple myeloma (MM) is the cancer of plasma cells within the bone marrow and remains incurable. Tumor-associated macrophages (TAMs) within the tumor microenvironment often display a pro-tumor phenotype and correlate with tumor proliferation, survival, and therapy resistance. IL-10 is a key immunosuppressive cytokine that leads to recruitment and development of TAMs.

View Article and Find Full Text PDF
Article Synopsis
  • R/R indolent non-Hodgkin lymphoma (iNHL) is often deemed incurable, but a phase 1b/2 study found that combining magrolimab (an anti-CD47 antibody) with rituximab (an anti-CD20 antibody) shows promising antitumor effects.
  • In this study, 46 patients were treated and showed a 52.2% overall response rate, with 30.4% achieving a complete response and median duration of response at 15.9 months.
  • Long-term follow-up (median 36.7 months) revealed no new toxicities or treatment-related deaths, indicating the combination's long-term safety and effectiveness, encouraging further research into CD
View Article and Find Full Text PDF

Background: Inflammation and insufficient physical inactivity contribute to individual-level risk of disease recurrence and death in stage III colon cancer. The extent to which increased inflammatory risk can be offset by sufficient physical activity remains unknown.

Methods: This cohort study was nested within the Cancer and Leukemia Group B (now part of the Alliance for Clinical Trials in Oncology) and Southwest Oncology Group randomized trial.

View Article and Find Full Text PDF

Quality of life and survivorship in patients with low-grade ovarian cancer.

Gynecol Oncol

November 2024

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, United States of America; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States of America. Electronic address:

Objective: High-grade (HGOC) and low-grade ovarian carcinoma (LGOC) are distinct malignancies with different biological features, treatment paradigms, and life expectancies. However, differences in quality of life (QOL), sleep, and depressive symptoms have not been examined by grade, and neither have inflammatory profiles associated with these symptoms. We aim to characterize QOL and biomarkers by OC grade.

View Article and Find Full Text PDF

Traversing the bench to bedside journey for iNKT cell therapies.

Front Immunol

August 2024

Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States.

Invariant natural killer T (iNKT) cells are immune cells that harness properties of both the innate and adaptive immune system and exert multiple functions critical for the control of various diseases. Prevention of graft-versus-host disease (GVHD) by iNKT cells has been demonstrated in mouse models and in correlative human studies in which high iNKT cell content in the donor graft is associated with reduced GVHD in the setting of allogeneic hematopoietic stem cell transplants. This suggests that approaches to increase the number of iNKT cells in the setting of an allogeneic transplant may reduce GVHD.

View Article and Find Full Text PDF

NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.

J Natl Compr Canc Netw

August 2024

National Comprehensive Cancer Network.

Article Synopsis
  • - Determining the best treatment plan for rectal cancer is complicated, involving choices between curative or palliative surgery and considering impact on bowel function and quality of life, especially for distal rectal cancer patients.
  • - Patients with rectal cancer face a higher risk of pelvic recurrence compared to those with colon cancer, making careful patient selection and a multidisciplinary treatment approach essential for better outcomes.
  • - Recent updates to the NCCN Guidelines for Rectal Cancer include new treatment options like endoscopic submucosal dissection for early cases, revisions to the total neoadjuvant therapy strategy, and a nonoperative "watch-and-wait" option for patients who respond well to initial therapy.
View Article and Find Full Text PDF

Somatic mutation phasing informs our understanding of cancer-related events, like driver mutations. We generated linked-read whole genome sequencing data for 23 samples across disease stages from 14 multiple myeloma (MM) patients and systematically assigned somatic mutations to haplotypes using linked-reads. Here, we report the reconstructed cancer haplotypes and phase blocks from several MM samples and show how phase block length can be extended by integrating samples from the same individual.

View Article and Find Full Text PDF

Is It Time to Resist Using RECIST as a Primary Endpoint for Rare Tumor Trials?

Clin Cancer Res

October 2024

Division of Medical Oncology, Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.

Article Synopsis
  • - Epithelioid hemangioendothelioma is a very rare type of cancer that is caused by a fusion of the YAP and CAMTA1 genes.
  • - A phase 2 clinical trial known as SARC33 tested trametinib, a drug related to the MEK signaling pathway, but the trial did not meet its main goals based on RECIST criteria.
  • - However, the trial showed positive patient-reported outcomes, indicating that participants experienced less pain.
View Article and Find Full Text PDF

Untargeted lipidomics reveals racial differences in lipid species among women.

Biomark Res

August 2024

Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, 660 South Euclid Avenue, Campus, Box 8100, St. Louis, MO, 63110, USA.

Understanding the biological mechanisms underlying racial differences in diseases is crucial to developing targeted prevention and treatment. There is, however, limited knowledge of the impact of race on lipids. To address this, we performed comprehensive lipidomics analyses to evaluate racial differences in lipid species among 506 non-Hispanic White (NHW) and 163 non-Hispanic Black (NHB) women.

View Article and Find Full Text PDF

Equipping the Public Health Workforce of the Future: Evaluation of an Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships.

J Public Health Manag Pract

August 2024

Author Affiliations: Prevention Research Center, Brown School at Washington University in St. Louis, St. Louis, Missouri (Dr Mazzucca-Ragan and Mrs Brownson); New England Public Health Training Center, Yale University, New Haven, Connecticut (Mrs Crouch); Rocky Mountain Public Health Training Center, Colorado School of Public Health, Aurora, Colorado (Mrs Davis); Yale-Griffin Prevention Research Center, Yale University, New Haven, Connecticut (Dr Duffany); School of Public Health, University of Alabama at Birmingham, Alabama, Birmingham (Dr Erwin); Rocky Mountain Prevention Research Center, Colorado School of Public Health, Aurora, Colorado (Dr Leiferman); Region IV Public Health Training Center, University of Alabama at Birmingham, School of Public Health, Alabama, Birmingham (Dr McCormick); Center for the Study of Community Health, University of Alabama at Birmingham, Alabama, Birmingham (Dr Walker); Prevention Research Center, Brown School at Washington University in St. Louis (Dr Brownson), St. Louis, Missouri; and Department of Surgery, Division of Public Health Sciences, and Alvin J. Siteman Cancer Center, Washington University School of Medicine, Washington University in St. Louis, St. Louis, Missouri (Dr Brownson).

Objective: Maintaining a skilled public health workforce is essential but challenging given high turnover and that few staff hold a public health degree. Situating workforce development within existing structures leverages the strengths of different organizations and can build relationships to address public health challenges and health equity. We implemented and evaluated an innovative, sustainable model to deliver an established evidence-based public health (EBPH) training collaboratively among Prevention Research Centers (PRC), local and state health departments, and Public Health Training Centers (PHTC).

View Article and Find Full Text PDF

Background: Premature aging is a significant concern in adult survivors of childhood cancer as they develop aging-related conditions at a younger age than their peers with no history of childhood cancer. Although modifiable lifestyle factors, such as diet, are postulated to affect aging process, supporting evidence is sparse.

Methods: We examined if the consumption of sugar and sugar-sweetened beverages was related to premature aging in 3322 adult survivors of childhood cancer in the St.

View Article and Find Full Text PDF

Urea cycle impairment and its relationship to obesity and inflammation remained elusive, partly due to the dramatic clinical presentation of classical urea cycle defects. We generated mice with hepatocyte-specific arginase 2 deletion (Arg2) and revealed a mild compensated urea cycle defect. Stable isotope tracing and respirometry revealed hepatocyte urea and TCA cycle flux defects, impaired mitochondrial oxidative metabolism, and glutamine anaplerosis despite normal energy and glucose homeostasis during early adulthood.

View Article and Find Full Text PDF